BACK TO CONTENTS Traditional model


Product centric;


business to business


Value Drivers Revenue / margins


Product effi cacy


Pitching


Acquisition of product companies


Product development


Approval based on clinical trial data


Information


Reimbursement based on real market effectiveness


Inorganic growth Brand Value Go-to-market strategy


Customer experience


Listening and


co-creating


Innovative partnerships


Innovation


Development of new businesses and markets


To fi nd out more, please contact:


Nathan Beaver Head of Customer &


Growth, KPMG in the UK nathan.beaver@kpmg.co.uk +44 (0)20 7694 2663


Business Model Transforming model


Customer centric;


business to customer


Health


outcomes for patients


The life sciences value


chain is no longer a simple linear process beginning with R&D and ending with sales visits to doctors. It is now more of a ‘value


ecosystem’ with the patient as customer at the centre


FOCUS 32


© 2014 KPMG LLP, a UK limited liability partnership, and a member fi rm of the KPMG network of independent member fi rms affi liated with KPMG International Cooperative, a Swiss entity. All rights reserved.


OUR WORLD


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41